Bacterial Infections  >>  apremilast  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
apremilast / Generic mfg.
NCT02695212: Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa

Completed
2
20
US
Apremilast
Florida Academic Dermatology Centers
Hidradenitis Suppurativa
08/17
08/17
SMASH, NCT03049267: Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis

Completed
2
20
Europe
Apremilast, Otezla, CC-10004, Placebo Oral Tablet, Placebo comparator
M.B.A. van Doorn, Celgene
Hidradenitis Suppurativa
12/17
06/18

Download Options